Salah-Dine Chibout Selected Research

Salah-Dine Chibout Research Topics

Disease

3	Tuberculosis (Tuberculoses) 01/2020 - 11/2016
3	Neoplasms (Cancer) 01/2018 - 02/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2017 - 10/2002
2	Diarrhea 01/2018 - 06/2016
2	Infections 08/2017 - 11/2016
2	Necrosis 06/2014 - 05/2011
2	Inflammation (Inflammations) 05/2011 - 09/2006
1	Granuloma 01/2020
1	Latent Tuberculosis 01/2020
1	Hemangiosarcoma (Angiosarcoma) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Psoriatic Arthritis 08/2017
1	Ankylosing Spondylitis 08/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2017
1	Pure Red-Cell Aplasia 02/2017
1	Hepatitis B 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Cholestasis 06/2016
1	Chemical and Drug Induced Liver Injury 06/2016
1	Non-alcoholic Fatty Liver Disease 06/2016
1	Blister (Bulla) 06/2014
1	Hypersensitivity (Allergy) 11/2012
1	Cataract (Cataracts) 03/2012
1	Rupture 03/2012
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2009
1	Pathologic Constriction (Stenosis) 09/2009
1	Carcinogenesis 01/2009
1	Coronary Disease (Coronary Heart Disease) 09/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2006
1	Lung Neoplasms (Lung Cancer) 05/2006
1	Drug-Related Side Effects and Adverse Reactions 09/2003
1	Skin Diseases (Skin Disease) 10/2002

Drug/Important Bio-Agent (IBA)

2	secukinumabIBA 01/2020 - 08/2017
2	Interleukin-17 (Interleukin 17)IBA 08/2017 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 06/2016 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 09/2006
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2020
1	Etanercept (Enbrel)FDA Link 01/2020
1	Adalimumab (Humira)FDA Link 01/2020
1	Ustekinumab (CNTO 1275)FDA Link 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	roblitinibIBA 01/2018
1	7 alpha-hydroxy-4-cholesten-3-oneIBA 01/2018
1	siponimodIBA 01/2018
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2018
1	CholesterolIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Monoclonal AntibodiesIBA 08/2017
1	Tyrosine Kinase InhibitorsIBA 04/2017
1	Sorafenib (BAY 43-9006)FDA Link 04/2017
1	arctigeninIBA 04/2017
1	Erythropoietin FDA Link 02/2017
1	TungstenIBA 02/2017
1	Telbivudine FDA Link 01/2017
1	adefovirIBA 01/2017
1	entecavir FDA Link 01/2017
1	Tenofovir (Viread)FDA Link 01/2017
1	Neutralizing AntibodiesIBA 11/2016
1	AntibodiesIBA 11/2016
1	Bile Acids and Salts (Bile Acids)IBA 06/2016
1	VildagliptinIBA 06/2014
1	Phenobarbital (Luminal)FDA Link 02/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	AllergensIBA 11/2012
1	2- (4- ((4- (6- methoxy- 3- pyridinyl)- 5- (4- (trifluoromethoxy)phenyl)- 2- thiazolyl)methoxy)- 2- methylphenoxy)acetic acidIBA 03/2012
1	PPAR deltaIBA 03/2012
1	ciglitazoneIBA 03/2012
1	Capsules (Microcapsules)IBA 03/2012
1	EnzymesIBA 05/2011
1	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 05/2011
1	RNA (Ribonucleic Acid)IBA 09/2009
1	XenobioticsIBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 09/2003
1	pimecrolimus (Elidel)FDA Link 10/2002

Therapy/Procedure

2	Therapeutics 11/2016 - 05/2006
1	Resuscitation 01/2020
1	Oral Administration 01/2018